Chirality—often described as "handedness"—is a fundamental property of nature, underlying the behavior of molecules ranging ...

Nanon Williams was sent to death row for a murder he says he didn't commit. Decades later, through daily emails and weekly ...

An elite Iranian military unit plotted to assassinate the Israeli ambassador to Mexico, according to a US official familiar with the matter. The plan, hatched by the Iranian Revolutionary Guard Corps’ ...

CSL Seqirus, the vaccine unit of Australian biotech CSL, has signed a pact to provide Saudi Arabia with cell-based influenza shots and help establish its production in-country. The move forms part of ...

Galapagos (NASDAQ:GLPG) ADRs dropped ~13% in the premarket on Tuesday after the Belgian biotech announced plans to wind down its cell therapy business, impacting roughly 365 employees in Europe, the U ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

The immune system has a tough job: When a tiny virus invades one of our cells, that cell must detect it and, within minutes, decide what to do. If the cell quickly self-destructs, that will prevent ...

(Reuters) -Novo Nordisk has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday. Bloomberg News first reported on ...

Ozempic maker Novo Nordisk (NVO) is closing its cell therapy division as part of a major restructuring drive initiated under the company’s new CEO, Mike Doustdar, Bloomberg News reported on Thursday, ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...